Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1363276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yangyang Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, RNA, Ribosomal, 16S, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Chronic kidney disease (CKD) is worldwide healthcare burden with growing incidence and death rate. Emerging evidence demonstrated the compositional and functional differences of gut microbiota in patients with CKD. As such, gut microbial features can be developed as diagnostic biomarkers and potential therapeutic target for CKD.
Methods
To eliminate the outcome bias arising from factors such as geographical distribution, sequencing platform, and data analysis techniques, we conducted a comprehensive analysis of the microbial differences between patients with CKD and healthy individuals based on multiple samples worldwide. A total of 980 samples from six references across three nations were incorporated from the PubMed, Web of Science, and GMrepo databases. The obtained 16S rRNA microbiome data were subjected to DADA2 processing, QIIME2 and PICRUSt2 analyses.
Results
The gut microbiota of patients with CKD differs significantly from that of healthy controls (HC), with a substantial decrease in the microbial diversity among the CKD group. Moreover, a significantly reduced abundance of bacteria Faecalibacterium prausnitzii (F. prausnitzii) was detected in the CKD group through linear discriminant analysis effect size (LEfSe) analysis, which may be associated with the alleviating effects against CKD. Notably, we identified CKD-depleted F. prausnitzii demonstrated a significant negative correlation with three pathways based on predictive functional analysis, suggesting its potential role in regulating systemic acidbase disturbance and pro-oxidant metabolism.
Discussion
Our findings demonstrated notable alterations of gut microbiota in CKD patients. Specific gut-beneficial microbiota, especially F. prausnitzii, may be developed as a preventive and therapeutic tool for CKD clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Center of Kidney and Urology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
- Shenzhen Key Laboratory for Systems Medicine in Inflammatory Diseases, School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, China.
Zitieren
APA
Zhang, Y., Zhong, W., Liu, W., Wang, X., Lin, G., Lin, J., Fang, J., Mou, X., Jiang, S., Huang, J., Zhao, W., & Zheng, Z. (2024). Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1363276
Vancouver
Zhang Y, Zhong W, Liu W, Wang X, Lin G, Lin J, et al. Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1363276
BibTeX
@article{Zhang2024,
author = {Zhang, Yangyang and Zhong, Weicong and Liu, Wenting and Wang, Xiaohua and Lin, Gan and Lin, Jiawen and Fang, Junxuan and Mou, Xiangyu and Jiang, Shan and Huang, Jiayuan and Zhao, Wenjing and Zheng, Zhihua},
title = {Uncovering specific taxonomic and functional alteration of gut microbiota in chronic kidney disease through 16S rRNA data},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1363276}
}
EUVIMED